Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Stephen K. Brannan

Director at Serina Therapeutics, Inc. (SER)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$30
Total bought / sold$2K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Jul 9SEC SERSerina Therapeutics, Inc. Buy 1,000new position $2.03 $2K -1.5%
  • Buy

    Director Stephen K. Brannan bought $2K of SER at $2.03 — first open-market purchase in our records; opens a new position.